Repligen
RGEN
#2389
Rank
โ‚น736.96 B
Marketcap
โ‚น13,065
Share price
-5.99%
Change (1 day)
22.92%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚น65.00 Billion

According to Repligen 's latest financial reports the company's total debt is โ‚น65.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น61.93 B5.21%
2024-12-31โ‚น58.87 B-0.65%
2023-12-31โ‚น59.25 B69.31%
2022-12-31โ‚น35.00 B28.46%
2021-12-31โ‚น27.24 B35.27%
2020-12-31โ‚น20.14 B7.27%
2019-12-31โ‚น18.77 B159.5%
2018-12-31โ‚น7.23 B14.19%
2017-12-31โ‚น6.33 B-2.12%
2016-12-31โ‚น6.47 B
2005-03-31โ‚น5.21 M40.38%
2004-03-31โ‚น3.71 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น6.024 T 9,168.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.080 T 6,176.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.916 T 2,848.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.388 T 6,651.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.40 B-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น27.89 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น38.39 B-40.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น27.44 B-57.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น136.08 B 109.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น288.90 B 344.47%๐Ÿ‡บ๐Ÿ‡ธ USA